Opioid-induced regulation of μ-opioid receptor gene expression in the MCF-7 breast cancer cell line

Biochemistry and Cell Biology

Volumn 86, Issue 3, 2008, Pages 217-226

  Gach, Katarzyna ^a   Piestrzeniewicz, Mariola ^a   Fichna, Jakub ^a   Stefanska, Barbara ^a   Szemraj, Janusz ^a   Janecka, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Endomorphins; Gene expression; Morphine; Naloxone; Opioid receptors

Indexed keywords

BIOACTIVITY; CELL CULTURE; CELLS; GENE EXPRESSION; MICROFLUIDICS; TRANSCRIPTION FACTORS;

BREAST CANCER CELLS; CONCENTRATION (COMPOSITION); HUMAN BREAST; IMMUNOBLOTTING; MCF 7 CELLS; MRNA EXPRESSION; MRNA LEVELS; OPIOID RECEPTORS; PROMOTER REGION; PROTEIN LEVELS; RECEPTOR (IR); RECEPTOR GENES; TIME-DEPENDENT;

TRANSCRIPTION;

ANTISERUM; ENDOMORPHIN 1; ENDOMORPHIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION;

ANALGESICS, OPIOID; BREAST NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NF-KAPPA B; OLIGOPEPTIDES; RECEPTORS, OPIOID, MU; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 44949227262     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O08-001     Document Type: Article

References (47)

1. Ammer, H., and Schulz, R. 1993. Alterations in the expression of G-proteins and regulation of adenylate cyclase in human neuroblastoma SH-SY5Y cells chronically exposed to low-efficacy μ-opioids. Biochem. J. 295: 263-271. PMID:8216227.
2. Arden, J.R., Segredo, V., Wang, Z., Lameh, J., and Sadee, W. 1995. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65: 1636-1645. PMID:7561859.
3. Beltran, J.A., Peek, J., and Chang, S.L. 2006. Expression and regulation of the mu opioid peptide receptor in TPA-differentiated HL-60 promyelocytic leukemia cells. Int. Immunopharmacol. 6: 1331-1340. doi:10.1016/j.intimp. 2006.03.017. PMID:16782547.
4. Bodnar, R.J., and Klein, G.E. 2005. Endogenous opiates and behavior: 2004. Peptides, 26: 2629-2711. doi:10.1016/j.peptides.2005.06.010. PMID:16039752.
5. Börner, C., Höllt, V., and Kraus, J. 2002. Involvement of activator protein-1 in transcriptional regulation of the human μ-opioid receptor gene. Mol. Pharmacol. 61: 800-805. doi:10.1124/mol.61.4.800. PMID:11901219.
6. Chakrabarti, S., Yang, W., Law, P.Y., and Loh, H.H. 1997. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation. Mol. Pharmacol. 52: 105-113. PMID:9224819.
7. Chang, S.L., Squinto, S.P., and Harlan, R.E. 1988. Morphine activation of c-fos expression in rat brain. Biochem. Biophys. Res. Commun. 157: 698-704. doi:10.1016/S0006-291X(88)80306-1. PMID:3144275.
8. Chomczynski, P., and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate - phenol - chloroform extraction. Anal. Biochem. 162: 156-159. doi:10.1016/0003-2697(87)90021-2. PMID:2440339.
9. Clark, M.J., and Traynor, J.R. 2005. Endogenous regulator of G protein signaling proteins reduce μ-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells. J. Pharmacol. Exp. Ther. 312: 809-815. doi:10.1124/jpet.104.074641. PMID:15383633.
10. Farooqui, M., Geng, Z.H., Stephenson, E.J., Zaveri, N., Yee, D., and Gupta, K. 2006. Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells. Mol. Cancer Ther. 5: 611-620. doi:10.1158/1535-7163.MCT-05- 0016. PMID:16546975.
11. Farooqui, M., Li, Y., Rogers, T., Poonawala, T., Griffin, R.J., Song, C.W., and Gupta, K. 2007. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br. J. Cancer, 97: 1523-1531. doi:10.1038/sj.bjc.6604057. PMID:17971769.
12. Fichna, J., and Janecka, A. 2004. Opioid peptides in cancer. Cancer Metastasis. Rev. 23: 351-366. doi:10.1023/B:CANC.0000031773.46458.63. PMID:15197335.
13. 125I]endomorphin-2 binding sites in the MCF7 breast cancer cell line. Peptides, 26: 295-299. doi:10.1016/j.peptides.2004.09.008. PMID:15629541.
14. Fichna, J., Gach, K., Piestrzeniewicz, M., Burgeon, E., Poels, J., Vanden Broeck, J., and Janecka, A. 2006. Functional characterization of opioid receptor ligands by aequorin luminescence-based calcium assay. J. Pharmacol. Exp. Ther. 317: 1150-1154. doi:10.1124/jpet.105.099986. PMID:16497786.
15. Grilli, M., Chiu, J.J., and Lenardo, M.J. 1993. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143: 1-62. PMID:8449662.
16. Gupta, K., Kshirsagar, S., Chang, L., Schwartz, R., Law, P.Y., Yee, D., and Hebbel, R.P. 2002. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 62: 4491-4498. PMID:12154060.
17. Harimaya, Y., Koizumi, K., Andoh, T., Nojima, H., Kuraishi, Y., and Saiki, I. 2002. Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells. Cancer Lett. 187: 121-127. doi:10.1016/S0304-3835(02)00360-9. PMID:12359359.
18. Hausdorff, W.P., Caron, M.G., and Lefkowitz, R.J. 1990. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J. 4: 2881-2889. PMID:2165947.
19. Horner, K.A., and Zadina, J.E. 2004. Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells. Brain Res. 1028: 121-132. doi:10.1016/j.brainres. 2004.07.055. PMID:15527737.
20. Janecka, A., Fichna, J., Kosson, P., Zalewska-Kaszubska, J., Krajewska, U., Mirowski, M., and Rozalski, M. 2004. Binding of the new morphiceptin analogs to human MCF-7 breast cancer cells and their effect on growth. Regul. Pept. 120: 237-241. doi:10.1016/j.regpep.2004.03.014. PMID:15177942.
21. Kallergi, G., Tsapara, A., Kampa, M., Papakonstanti, E.A., Krasagakis, K., Castanas, E., and Stournaras, C. 2003. Distinct signaling pathways regulate differential opioid effects on actin cytoskeleton in malignant MCF7 and nonmalignant MCF12A human breast epithelial cells. Exp. Cell Res. 288: 94-109. doi:10.1016/S0014-4827(03)00210-6. PMID:12878162.
22. Kato, S., Fukuda, K., Morikawa, H., Shoda, T., Mima, H., and Mori, K. 1998. Adaptations to chronic agonist exposure of μ-opioid receptor expressing Chinese hamster ovary cells. Eur. J. Pharmacol. 345: 221-228. doi:10.1016/S0014-2999(98)00023-5. PMID:9600641.
23. Kraus, J., Börner, C., Giannini, E., and Höllt, V. 2003. The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human μ-opioid receptor gene. Mol. Pharmacol. 64: 876-884. doi:10.1124/mol.64.4.876.
24. Law, P.Y., Hom, D.S., and Loh, H.H. 1982. Loss of opiate receptor activity in neuroblastoma x glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process. Mol. Pharmacol. 22: 1-4. PMID:6126803.
25. Law, P.Y., Hom, D.S., and Loh, H.H. 1984. Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells. Chloroquine promotes accumulation of tritiated enkephalin in the lysosomes. J. Biol. Chem. 259: 4096-4104. PMID:6323457.
26. Lin, X., Li, Q., Wang, Y.J., Ju, Y.W., Chi, Z.Q., Wang, M.W., and Liu, J.G. 2007. Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells. Biochem. J. 406: 215-221. doi:10.1042/BJ20070186. PMID:17542780.
27. Maneckjee, R., and Minna, J.D. 1992. Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells. Proc. Natl. Acad. Sci. U.S.A. 89: 1169-1173. doi:10.1073/pnas.89.4.1169. PMID:1311082.
28. Maneckjee, R., Biswas, R., and Vonderhaar, B.K. 1990. Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res. 50: 2234-2238. PMID:2156613.
29. Mao, J., Sung, B., Ji, R.R., and Lim, G. 2002. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J. Neurosci. 22: 7650-7661. PMID:12196588.
30. Mestek, A., Hurley, J.H., Bye, L.S., Campbell, A.D., Chen, Y., Tian, M., et al. 1995. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15: 2396-2406. PMID:7891175.
31. Minami, M., and Satoh, M. 1995. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci. Res. 23: 121-145. doi:10.1016/0168-0102(95)00933-K. PMID:8532211.
32. Morgan, J.I., and Curran, T. 1991. Stimulus-transcription coupling in the nervous system: involvement of the inducible protooncogenes fos and jun. Annu. Rev. Neurosci. 14: 421-451. doi:10.1146/annurev.ne.14.030191.002225. PMID:1903243.
33. Nylund, G., Pettersson, A., Bengtsson, C., Khorram-Manesh, A., Nordgren, S., and Delbro, D.S. 2007. Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon. Dig. Dis. Sci. [Epub ahead of print].
34. Puttfarcken, P.S., and Cox, B.M. 1989. Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells. Life Sci. 45: 1937-1942. doi:10.1016/0024-3205(89)90548-1. PMID:2557508.
35. Reisine, T., and Pasternak, G. 1996. Opioid analgesics and antagonists. In Goodman and Gilman's pharmacological basis of therapeutics. Edited by J.G.L. Hardman and L.E. Limbird. McGraw-Hill, N.Y. pp. 521-555.
36. Roy, S., Cain, K.J., Chapin, R.B., Charboneau, R.G., and Barke, R.A. 1998. Morphine modulates NF kappa B activation in macrophages. Biochem. Biophys. Res. Commun. 245: 392-396. doi:10.1006/bbrc.1998.8415. PMID:9571161.
37. Sasamura, T., Nakamura, S., Iida, Y., Fujii, H., Murata, J., Saiki, I., et al. 2002. Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur. J. Pharmacol. 441: 185-191. doi:10.1016/S0014-2999(02)01450-4. PMID:12063091.
38. Satoh, M., and Minami, M. 1995. Molecular pharmacology of the opioid receptors. Pharmacol. Ther. 68: 343-364. doi:10.1016/0163-7258(95)02011- X. PMID:8788562.
39. Sharma, S.K., Klee, W.A., and Nirenberg, M. 1977. Opiate-dependent modulation of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 74: 3365-3369. doi:10.1073/pnas.74.8.3365. PMID:269396.
40. Singhal, P.C., Kapasi, A.A., Reddy, K., Franki, N., Gibbons, N., and Ding, G. 1999. Morphine promotes apoptosis in Jurkat cells. J. Leukoc. Biol. 66: 650-658. PMID:10534122.
41. Tegeder, I., and Geisslinger, G. 2004. Opioids as modulators of cell death and survival-unraveling mechanisms and revealing new indications. Pharmacol. Rev. 56: 351-369. doi:10.1124/pr.56.3.2. PMID:15317908.
42. Tegeder, I., Grosch, S., Schmidtko, A., Häussler, A., Schmidt, H., Niederberger, E., et al. 2003. G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res. 63: 1846-1852. PMID:12702572.
43. Welters, I.D., Menzebach, A., Goumon, Y., Cadet, P., Menges, T., Hughes, T.K., et al. 2000. Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology, 92: 1677-1684. doi:10.1097/00000542-200006000-00027. PMID:10839919.
44. Winer, J., Jung, C.K., Shackel, I., and Williams, P.M. 1999. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270: 41-49. doi:10.1006/abio.1999.4085. PMID:10328763.
45. Wu, W.R., Zheng, J.W., Li, N., Bai, H.Q., Zhang, K.R., and Li, Y. 1999. Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice. Eur. J. Pharmacol. 366: 261-269. doi:10.1016/S0014-2999(98)00915-7. PMID:10082208.
46. Zarnegar, P., Persson, A.I., Ming, Y., and Terenius, L. 2006. Opioid-induced regulation of gene expression in PC12 cells stably transfected with mu-opioid receptor. Neurosci. Lett. 396: 197-201. doi:10.1016/j.neulet.2005.11.040. PMID:16377088.
47. Zong, J., and Pollack, G.M. 2000. Morphine antinociception is enhanced in mdr1a gene-deficient mice. Pharm. Res. 17: 749-753. doi:10.1023/A: 1007546719287. PMID:10955852.